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by Salmonella Enteritidis after oral vaccination 
of laying hens with Salmonella Enteritidis ΔtolC 
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Abstract 
Vaccination of laying hens has been successfully used to reduce egg contamination by Salmonella Enteritidis, decreas-
ing human salmonellosis cases worldwide. Currently used vaccines for layers are either inactivated vaccines or live 
attenuated strains produced by mutagenesis. Targeted gene deletion mutants hold promise for future vaccines, 
because specific bacterial functions can be removed that may improve safety and allow differentiation from field 
strains. In this study, the efficacy of Salmonella Enteritidis ΔtolC and ΔacrABacrEFmdtABC strains in laying hens as live 
vaccines was evaluated. The mutants are deficient in either the membrane channel TolC (ΔtolC) or the multi-drug 
efflux systems acrAB, acrEF and mdtABC (ΔacrABacrEFmdtABC). These strains have a decreased ability for gut and tis-
sue colonization and are unable to survive in egg white, the latter preventing transmission of the vaccine strains to 
humans. Two groups of 30 laying hens were orally inoculated at day 1, 6 weeks and 16 weeks of age with 108 cfu of 
either vaccine strain, while a third group was left unvaccinated. At 24 weeks of age, the birds were intravenously chal-
lenged with 5 × 107 cfu Salmonella Enteritidis PT4 S1400/94. The vaccine strains were not shed or detected in the gut, 
internal organs or eggs, 2 weeks after the third vaccination. The strains significantly protected against gut and internal 
organ colonization, and completely prevented egg contamination by Salmonella Enteritidis under the conditions of 
this study. This indicates that Salmonella Enteritidis ΔtolC and ΔacrABacrEFmdtABC strains might be valuable strains for 
vaccination of layers against Salmonella Enteritidis.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Salmonella Enteritidis first emerged in the 1980s as a 
significant threat to public health worldwide. Eggs were 
identified as the main food vehicle causing human ill-
ness [1, 2]. A sustained commitment of the authorities, 
implementation of Salmonella control programs and 
serious investment in Salmonella research led to inter-
national progress in decreasing the incidence of both egg 
contamination [3] and human infections [4]. Vaccination 
in particular contributed to the decline in the number of 
recorded human cases of Salmonella Enteritidis [5]. Both 
inactivated and live vaccines have been shown to reduce 
Salmonella colonization in layers and contamination 
of eggs [6–8]. Several live vaccines were developed and 
proven to be efficient against Salmonella colonization 
[9–11]. Live vaccines may stimulate both cell-mediated 
and humoral immunity, can induce rapid protection by 
colonization-inhibition and are easy to administer, i.e. 
through the drinking water [6, 12]. A major concern of 
live vaccines however is safety, including the possible 
risk of reversion to virulence [13]. Whole gene dele-
tion mutants are generally considered to be less capa-
ble of reversion to a virulent phenotype as compared to 
strains harboring point mutations or undefined genetic 
alterations. For Salmonella Enteritidis, a lot of knowl-
edge has been generated on the function of many of the 
chromosomal genes, and targeted deletions of specific 
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genes related to virulence or persistence in a host have 
been used to construct live vaccine strains [14–18]. In 
the case of Salmonella vaccines for laying hens, the issue 
of vaccine safety has an additional dimension, as safety 
should not only include the target species, but also the 
risk of transmission to humans through consumption of 
the eggs. Deleting genes important for virulence in mam-
mals, but also deleting genes that are involved in egg 
white survival can be a key issue because this will prevent 
transmission of the vaccine strains to the egg consumers.
Egg white survival is a key characteristic of Salmonella 
Enteritidis transmission to humans. Because of the low 
pH, iron restricting conditions and the presence of a vari-
ety of antimicrobial molecules, egg white is an antimicro-
bial matrix [19]. Lipopolysaccharide (LPS) structure [20], 
lysozyme inhibitors [21] and protein and DNA damage 
repair mechanisms [22, 23] are important in egg white 
survival of Salmonella. Deleting genes encoding these 
functions could thus generate strains with a deficient egg 
white survival. Recently obtained data suggested that the 
multi-drug resistance (MDR) pump systems and the TolC 
outer membrane channel, through which MDR pumps 
export antibacterial molecules out of the bacterial cell, 
are also involved in egg white survival [24]. Siderophore 
export through TolC counteracting iron-deprivation in 
egg white, or MDR pump-mediated export of antimicro-
bial molecules out of the bacterial cell may be involved in 
this [23, 25].
In the current study, we aimed to evaluate the effi-
ciency of the Salmonella Enteritidis ΔtolC and 
ΔacrABacrEFmdtABC strains, the latter devoid in three 
MDR efflux pumps, as live vaccines for protection against 
Salmonella Enteritidis egg contamination and tissue col-
onization in laying hens.
Materials and methods
Vaccine and challenge strains
The vaccine strains ΔtolC and ΔacrABacrEFmdtABC 
are defined mutants of Salmonella Enteritidis 147 phage 
type 4. The wild type strain 147 was originally isolated 
from egg white and is resistant to streptomycin. The 
strain is known to colonize the gut and internal organs 
to a high level [26, 27]. All mutations were constructed 
according to the one step inactivation method previously 
described by Datsenko and Wanner [28]. Briefly, for the 
ΔtolC mutant, a kanamycin resistance cassette, flanked 
by FRT-sites, was amplified from the pKD4 plasmid with 
specific primers, homologous with the flanking region of 
the target gene. The resulting PCR product was used for 
recombination on the Salmonella Enteritidis 147 strain 
chromosome using the pKD20 helper plasmid encoding 
the λ Red system, promoting recombination between the 
native gene and PCR adjusted antibiotic resistance cas-
sette. Recombinant clones were selected on kanamycin 
containing plates. Replacement of the target gene by the 
resistance cassette was confirmed by PCR. The deletion 
was P22-transduced into a new Salmonella Enteritidis 
147 strain. The antibiotic resistance cassette was elimi-
nated using the pCP20 helper plasmid, encoding the 
FLP-recombinase, mediating recombination between the 
FRT-sites flanking the kanamycin resistance cassette. For 
the ΔacrABacrEFmdtABC strain, the procedure was car-
ried out in three steps, successively deleting the acrAB, 
acrEF and mdtABC genes. P22 transduction was done 
in the stepwise generated mutants. All targeted genes 
were completely deleted from start to stop codon, as con-
firmed by sequencing analysis. Salmonella Enteritidis 
S1400/94 was used as a challenge strain. The character-
istics of this strain have been described previously [29].
The challenge and vaccine strains were incubated over-
night with gentle agitation at 37 °C in Luria–Bertani (LB) 
medium (Sigma, ST. Louis, MO, USA). To determine 
bacterial titers, tenfold dilutions were plated on brilliant 
green agar (BGA, Oxford, Basingstoke, Hampshire, UK) 
for the challenge strain. The vaccine strains were plated 
on LB supplemented with 1% lactose, 1% phenol red and 
100 µg/mL streptomycin to determine the titer, because 
these strains do not grow on traditional Salmonella 
culture media. The vaccine and challenge strains were 
diluted in HBSS (Hanks Balanced Salt Solution, Invitro-
gen, Paisley, UK) to 108 cfu/mL.
Experimental birds
Ninety (90) day-old Lohmann Brown laying hens (De 
Biest, Kruishoutem, Belgium) were randomly divided 
into three groups and housed in separate units. Commer-
cial feed and drinking water was provided ad libitum. The 
animal experiment in this study followed the institutional 
guidelines for the care and use of laboratory animals 
and was approved by the Ethical Committee of the Fac-
ulty of Veterinary Medicine, Ghent University, Belgium 
(EC2013/135). Euthanasia was performed with an over-
dose of sodium pentobarbital in the wing vein.
Experimental setup
Two different groups (n  =  30) of animals were orally 
immunized at day of hatch, at 6  weeks of age and at 
16 weeks of age through crop instillation of 0.5 mL con-
taining 108  cfu Salmonella Enteritidis 147 ΔtolC (group 
1) or Salmonella Enteritidis 147 ΔacrABacrEFmdtABC 
(group 2). A third group of birds (n  =  30) was kept as 
non-immunized but Salmonella challenged positive 
controls (group 3). At the age of 18  weeks, serum sam-
ples were taken for quantification of anti-Salmonella 
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Enteritidis antibodies in an LPS-ELISA [30]. At the same 
time, cloacal swabs were taken in each group and bac-
teriologically analyzed for the presence of the vaccine 
strains. At 21 weeks of age, all the hens were in lay. Eggs 
were collected daily during 3  weeks for bacteriologi-
cal detection of the vaccine strain in the egg content. At 
24 weeks of age, all the animals were intravenously inocu-
lated in the wing vein with 0.5 mL containing 5 × 107 cfu 
of the Salmonella Enteritidis challenge strain S1400/94. 
This protocol was already used previously to produce 
high levels of internal egg contamination [10, 31]. The 
eggs were collected daily during 3  weeks after inocula-
tion and analyzed for the presence of the challenge strain. 
Three weeks after challenge inoculation, all the animals 
were euthanized by an overdose of pentobarbital in the 
wing vein. Samples of the spleen, oviduct, ovary, uterus 
and caecum were aseptically removed for bacteriological 
quantification of challenge and vaccine strain bacteria.
ELISA to quantify anti‑LPS antibodies
For analysis of anti-Salmonella LPS antibodies in serum 
samples, a previously described indirect ELISA protocol 
was used [30]. Three 96 well-plates (Sigma) were coated 
with 100  µL of an LPS solution (10  µg/mL) in 0.05  M 
carbonate-bicarbonate (pH 9.6; coating buffer) and incu-
bated for 24  h at 4  °C. The LPS was purified from Sal-
monella Enteritidis PT4 strain. The plates were rinsed 
four times with phosphate buffered saline (PBS, Sigma) 
supplemented with 0.1% Tween-20 (Sigma; washing 
buffer) between each step. In the first step, 100  µL PBS 
(Sigma) supplemented with 1% bovine serum albumin 
(BSA, Sigma; blocking buffer) was added to the wells 
for 1 h at 37 °C. The blocking buffer was then removed. 
Secondly, serum samples of animals from the different 
groups were diluted in blocking buffer (1:200) and added 
to the plates (100  µL). As an internal negative control, 
serum from a Salmonella free chick was used. Serum 
from a chick that had been infected experimentally with 
Salmonella Enteritidis PT4, strain 76Sa88, was used as 
an internal positive control. The plates were incubated 
on a shaking platform for 2  h at 37  °C. Thirdly, peroxi-
dase-labelled rabbit anti-chick IgG (100  µL, Sigma) was 
diluted (1:2000) in blocking buffer and added to the wells 
for 1 h and 30 min while shaking at 37 °C. Finally 50 µL 
of TMB substrate (Fisher Scientific, Erembodegem, Bel-
gium) was added to the wells. The reaction was blocked 
with 50 µL of sulfuric acid (0.5 M). The absorbance was 
measured in an ELISA reader at 450  nm. Every sample 
was analyzed in duplicate. Data were shown as S/P ratios, 
thus [OD(sample) − OD(negative control)]/[OD(positive 
control) −  OD(negative control)]. Negative values were 
considered as zero.
Bacteriological examination of the challenged birds
Cloacal swabs taken at week 18 were incubated overnight 
at 37 °C in buffered peptone water (BPW, Oxoid, Basing-
stoke, Hampshire, UK). Afterwards a loopful was plated 
on LB plates supplemented with 1% lactose, 1% phenol 
red and 100 µg/mL streptomycin (Sigma) for the detec-
tion of the vaccine strains Salmonella Enteritidis 147 
ΔtolC and ΔacrABacrEFmdtABC.
Samples of caecum, spleen, ovary, oviduct and uterus 
were homogenized in BPW (10% weight/volume suspen-
sions) and tenfold dilutions were made in HBSS (Invitro-
gen). Six droplets of 20  µL of each dilution were plated 
on BGA (for quantification of the challenge strain) or on 
LB supplemented with 1% lactose, 1% phenol red and 
100  µg/mL streptomycin (for quantification of the vac-
cines). After overnight incubation at 37  °C, the number 
of cfu/g tissue was determined by counting the number 
of bacterial colonies for the appropriate dilution. Sam-
ples that tested negative after direct plating for the chal-
lenge strain were enriched in tetrathionate brilliant green 
broth (Oxoid, Basingstoke, UK) by overnight incubation 
at 37  °C. After incubation, a loopful of the tetrathionate 
brilliant green broth was plated on BGA.
Egg production and bacteriological examination of eggs
Eggs were collected daily for 6  weeks from week 21 
onwards and the egg production was determined. Each 
day, eggs of six hens per group were pooled in one batch, 
yielding an egg per batch number that varied between 
one and six. Upon collection, lugol solution and 95% 
ethanol were used to decontaminate the surface of the 
eggshell. After decontamination of the eggshell, the eggs 
were broken aseptically and the total content of the eggs 
was pooled and homogenized per batch. A volume of 
40 mL of BPW was added for each egg to the pooled egg 
content and incubated for 48  h at 37  °C. To detect the 
vaccine strains, a loopful of the BPW broth was plated 
on LB plates supplemented with 1% lactose, 1% phenol 
red and 100 µg/mL streptomycin. To detect the challenge 
strain, a loopful of the BPW broth was plated on BGA. 
Additionally, further enrichment was done overnight at 
37 °C in tetrathionate brilliant green broth and after incu-
bation, a loopful of broth culture was streaked onto BGA.
Statistical analysis
SPSS 22.0 software was used for statistical analysis. Cloacal 
swabs, batches of eggs and data of cfu Salmonella/gram tis-
sue of the caecum, spleen, ovary, oviduct and uterus after 
enrichment were categorized as either positive or negative. 
A binary regression model was used to determine differences 
between the groups. For all tests, differences with p values 
below 0.05 were considered to be statistically significant.
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Results
Detection of anti‑Salmonella LPS antibodies in serum
Data derived from the LPS-ELISA are shown in Fig-
ure  1. The data are represented as S/P ratios, thus 
[OD(sample) − OD(negative control)]/[OD(positive con-
trol) − OD(negative control)].
Analysis of cloacal swabs and eggs for the presence 
of vaccine strains
Not a single Salmonella vaccine isolate was obtained 
from cloacal swabs or egg content samples.
Clinical signs and egg production after challenge
Over the whole experiment, there was no reduction in 
feed and water intake in either of the groups. The egg 
production rate after infection in the unvaccinated con-
trol group dropped to 59% in the first week post-infec-
tion (pi) and raised to 75 and 86% in the second and third 
week pi. The egg production rate did not decrease signifi-
cantly after challenge in the vaccinated groups. The egg 
production percentage in the group vaccinated with the 
ΔtolC strain was 60, 100 and 90%, in the first, second and 
third week after challenge. In the group vaccinated with 
the ΔacrABacrEFmdtABC strain, the egg production per-
centage was 56, 70 and 68% respectively. Some eggs were 
thin-shelled and malformed during the first week after 
infection. At the end of the experiment, 11 hens died 
in the group of animals vaccinated with the Salmonella 
Enteritidis 147 ΔacrABacrEFmdtABC strain because of 
cannibalism.
Isolation of the challenge strain from egg contents
Not a single Salmonella positive egg batch was detected 
from animals vaccinated with the Salmonella Ente-
ritidis 147 ΔtolC and Salmonella Enteritidis 147 
ΔacrABacrEFmdtABC strains (Table  1). During the first 
week, three egg batches out of 26 were Salmonella posi-
tive in the non-vaccinated control group at direct plating. 
In the third week pi, no positive egg batches were found.
Isolation of the challenge strain from the organs at 3 weeks 
post‑infection
No samples were positive at direct plating. Table 2 pre-
sents the percentage of Salmonella-positive organ sam-
ples after enrichment, in vaccinated and non-vaccinated 
groups, at 3  weeks post challenge. Vaccination with the 
Salmonella Enteritidis 147 ΔtolC strain significantly 
decreased the number of Salmonella positive samples in 
the spleen, caecum and ovary as compared to the control 
group. Vaccination with the ΔacrABacrEFmdtABC strain 
significantly reduced the number of Salmonella positive 
samples in the ovary and oviduct.
Figure 1 [OD(sample) − OD(negative control)]/[OD(positive 
control) − OD(negative control)] measured in the ELISA 
detecting anti-Salmonella LPS antibodies. Serum of 18-week old 
laying hens, vaccinated at day 1, 6 weeks of age and 16 weeks of age 
with Salmonella Enteritidis 147 ΔtolC and Salmonella Enteritidis 147 
ΔacrABacrEFmdtABC was analysed.
Table 1 Percentage of egg content batches positive for the 
challenge strain Salmonella Enteritidis S1400/94
Animals were vaccinated at day one, 6 weeks and 16 weeks of age with 108 
cfu of either Salmonella Enteritidis 147 ΔtolC or Salmonella Enteritidis 147 
ΔacrABacrEFmdtABC strains or kept as non-immunized controls. Results 
are shown for egg content samples, plated on BGA after BPW (48 h, 37 °C) 
incubation. Percentage of batches positive after enrichment in tetrathionate 
brilliant green broth (37 °C, overnight) are shown between brackets. Different 
superscripts within a column indicate significant differences between the 
groups (p < 0.05).
Group Week 1 Week 2
Non-vaccinated 70a (74)a 0 (17)a
ΔtolC 0b (0)b 0 (0)b
ΔacrABacrEFmdtABC 0b (0)b 0 (0)b
Table 2 Percentage of Salmonella-positive samples after 
enrichment
Samples of uterus, spleen, caecum, ovary and oviduct were taken, 3 weeks post-
infection with Salmonella Enteritidis S1400/94. Animals were vaccinated at day 
1, week 6 and week 16 with either Salmonella Enteritidis 147 ΔtolC or Salmonella 
Enteritidis 147 ΔacrABacrEFmdtABC. Statistically significant differences (p < 0.05) 
in percentage of positive organ samples between vaccinated groups and the 
non-vaccinated control group are indicated with an asterisk.
Control ΔtolC ΔacrABacrEFmdtABC
Uterus 13.3 10 15.9
Spleen 80 50* 63.2
Caecum 30 6.6* 0*
Ovary 70 36.6* 31.6*
Oviduct 46.6 30 5.3*
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Discussion
Current commercial live vaccines contain strains har-
boring undefined mutations in one or more genes on the 
chromosome or defined point mutations. Strains har-
boring (undefined or defined) point mutations might, 
however, revert to a virulent phenotype and are thus con-
sidered to be unsafe [13, 32]. Future live vaccines should 
therefore contain fully defined strains carrying (multiple) 
gene deletions for purposes of safety. Deletion of entire 
genes additionally permits differentiation from wild type 
strains, allowing quality control. Numerous experimen-
tal vaccines were already tested in various animal hosts, 
including chickens, but data on the protection of these 
live vaccines against egg contamination are scarce [10, 
17, 18].
Successful attenuation of the wild type strain requires 
prior knowledge of the pathogen’s virulence factors. A 
vaccine strain used for the prevention of (vertical) egg 
contamination of Salmonella Enteritidis ideally colonizes 
and induces local immunity in the reproductive tract. 
From a public health point of view, it may not persist 
here and preferably does not survive in egg white. A logi-
cal approach is to eliminate genes playing a role in egg 
white survival. In the current study defined mutants in 
MDR transporters and the TolC outer membrane chan-
nel were used as vaccine strains. The TolC promoter is 
activated after contact with egg white at 42  °C, but not 
under standard “in vitro” culture conditions [24]. The 
TolC outer membrane channel is used by MDR trans-
porters (e.g. acrAB, acrEF, mdtABC) to export host 
antibacterial compounds and bacterial molecules such 
as siderophores, and is involved in survival in harmful 
environments, including egg white [33]. The ΔtolC and 
ΔacrABacrEFmdtABC vaccine strains can no longer sur-
vive in egg white, thereby eliminating the risk of human 
exposure through eggs [24]. To our knowledge, these 
genes were never associated with protective immunity in 
chickens, allowing wild type-like antigen presentation.
The actual immune mechanism explaining the protec-
tion against Salmonella Enteritidis colonization observed 
in the current trial is not completely clear. Immunization 
with Salmonella vaccines can induce variable humoral 
and cell-mediated responses that do not always corre-
late with acquired resistance to re-infection [34]. A role 
for humoral responses in the clearance of Salmonella 
infections has been shown for using inactivated vaccines, 
which are less able to induce cellular responses but are 
still partially protective [35]. Cell-mediated immunity 
was not investigated during this trial but for Salmonella 
in poultry, susceptibility to the infection is correlated 
with a fall in CD4+ and CD8+ T-lymphocytes and γδ 
T-lymphocytes in the oviduct, and with T-lymphocyte 
hyporesponsiveness [36]. Live vaccines have been shown 
to increase numbers of CD4+ and CD8+ T-lympho-
cytes to a certain level in the gut wall [37]. Future stud-
ies should further investigate the role of the humoral 
and cellular immune responses during vaccine-induced 
protection. Possibly a combination of cell-mediated 
immunity and a strong humoral response are yielding 
additional protective effects.
To conclude, data from this trial indicate that Salmo-
nella Enteritidis ΔtolC and ΔacrABacrEFmdtABC strains 
are safe vaccines that can induce protection against inter-
nal organ colonization after intravenous inoculation of 
a Salmonella Enteritidis challenge strain. The vaccine 
strains were able to completely prevent egg contamination 
with Salmonella Enteritidis in the current in vivo trial.
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